[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @GeneOnlineNews GeneOnline GeneOnline posts on X about investment, poland, vera, sarepta therapeutics the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::889321711966998528/interactions)  - X Week XXX +30% - X Month XXXXX +357% - X Months XXXXX +18% - X Year XXXXXX +89% ### Mentions: X [#](/creator/twitter::889321711966998528/posts_active)  ### Followers: XXXXX [#](/creator/twitter::889321711966998528/followers)  - X Week XXXXX +0.04% - X Month XXXXX +0.17% - X Months XXXXX -XXXX% - X Year XXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::889321711966998528/influencer_rank)  ### Social Influence [#](/creator/twitter::889321711966998528/influence) --- **Social category influence** [countries](/list/countries) [finance](/list/finance) [stocks](/list/stocks) [technology brands](/list/technology-brands) **Social topic influence** [investment](/topic/investment), [poland](/topic/poland), [vera](/topic/vera), [sarepta therapeutics](/topic/sarepta-therapeutics), [insurance](/topic/insurance), [realworld](/topic/realworld), [taiwan](/topic/taiwan), [$2353tw](/topic/$2353tw), [acer](/topic/acer), [$4904tw](/topic/$4904tw) **Top assets mentioned** [Alphabet Inc Class A (GOOGL)](/topic/$googl) ### Top Social Posts [#](/creator/twitter::889321711966998528/posts) --- Top posts by engagements in the last XX hours "At the BIO International Convention 2025 Magdalena KulczyckaPh.D. President of BioForum shared how Poland is transforming its life sciences sector through steady R&D investment clinical trial capacity and cross-border collaboration. With over XXX biotech companies Poland is becoming a strategic connector in Central and Eastern Europe. Its strengths include a cost-effective EU-aligned clinical trial network a growing presence in ATMPs and drug development and an SME-driven ecosystem ready for global partnerships. But challenges remain: investor education access to long-term capital and the"  [@GeneOnlineNews](/creator/x/GeneOnlineNews) on [X](/post/tweet/1950398390371844442) 2025-07-30 03:29:47 UTC 4756 followers, XX engagements "During BIO AsiaTaiwan 2025 GeneOnline visited PharmaEssentia a global biopharmaceutical company known for developing innovative therapies for hematologic malignancies cancers and immune-related diseases. The company outlined its four strategic pillars for growth: 1) Ropeginterferon alfa-2b (BESREMi) a long-acting mono-pegylated interferon already approved for polycythemia vera in the U.S. EU and Asia 2) a growing immune-oncology pipeline featuring anti-TIM-3 and anti-PD-1 checkpoint inhibitors 3) its proprietary PEGylation platform for creating long-acting biologics Stay informed throughout"  [@GeneOnlineNews](/creator/x/GeneOnlineNews) on [X](/post/tweet/1948338551248310716) 2025-07-24 11:04:43 UTC 4756 followers, XX engagements "Sarepta Therapeutics has received @FDA clearance to resume shipments of ELEVIDYS for ambulatory patients with Duchenne muscular dystrophy (DMD) after a voluntary pause prompted by safety concerns. While shipments remain paused for non-ambulatory patients due to serious risks this decision is a positive step forward for younger patients still able to walk. ELEVIDYS is the only FDA-approved gene therapy targeting the underlying cause of DMD. Delivered via a single dose using an adeno-associated virus it offers hope to families seeking treatment options. Sareptas CEO Douglas S. Ingram emphasized"  [@GeneOnlineNews](/creator/x/GeneOnlineNews) on [X](/post/tweet/1950394624637300788) 2025-07-30 03:14:49 UTC 4755 followers, XX engagements "As part two of Session A-11 on digital health at BIO AsiaTaiwan 2025 experts from Google Health2Sync Far EasTone Telecommunication Acer Medical and Deloitte Taiwan presented practical use cases demonstrating how digital health innovations are driving real-world clinical and operational impact. Tony Lee of Google discussed AI collaborations with Taiwans National Health Insurance Administration to predict diabetes onset and improve early intervention. Ed Deng of Health2Sync shared how the company is scaling chronic disease management across Asia through data-driven patient-centric tools. Peter"  [@GeneOnlineNews](/creator/x/GeneOnlineNews) on [X](/post/tweet/1948715497677357288) 2025-07-25 12:02:34 UTC 4757 followers, XX engagements "Biotech Without Borders Innovating the Future At this year's BIO AsiaTaiwan 2025 conference My Linh Kha Senior Vice President and General Manager of Japan Asia Pacific at @Amgen delivered a keynote speech on "Biotech Without Borders: Unlocking the Future Through Innovation and Collaboration." She also shared her perspective on AI and innovation at Amgen with GeneOnline. "Innovation can and should move at the speed of need." My Linh Kha Three Key Takeaways: - Amgen's Foundation of Success: Rooted in a commitment to "pioneering science" an "unwavering commitment to patients" and a deep "belief"  [@GeneOnlineNews](/creator/x/GeneOnlineNews) on [X](/post/tweet/1949027264353763731) 2025-07-26 08:41:25 UTC 4754 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@GeneOnlineNews GeneOnline
GeneOnline posts on X about investment, poland, vera, sarepta therapeutics the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX +30%
- X Month XXXXX +357%
- X Months XXXXX +18%
- X Year XXXXXX +89%
Mentions: X #
Followers: XXXXX #
- X Week XXXXX +0.04%
- X Month XXXXX +0.17%
- X Months XXXXX -XXXX%
- X Year XXXXX -XXXX%
CreatorRank: undefined #
Social Influence #
Social category influence countries finance stocks technology brands
Social topic influence investment, poland, vera, sarepta therapeutics, insurance, realworld, taiwan, $2353tw, acer, $4904tw
Top assets mentioned Alphabet Inc Class A (GOOGL)
Top Social Posts #
Top posts by engagements in the last XX hours
"At the BIO International Convention 2025 Magdalena KulczyckaPh.D. President of BioForum shared how Poland is transforming its life sciences sector through steady R&D investment clinical trial capacity and cross-border collaboration. With over XXX biotech companies Poland is becoming a strategic connector in Central and Eastern Europe. Its strengths include a cost-effective EU-aligned clinical trial network a growing presence in ATMPs and drug development and an SME-driven ecosystem ready for global partnerships. But challenges remain: investor education access to long-term capital and the"
@GeneOnlineNews on X 2025-07-30 03:29:47 UTC 4756 followers, XX engagements
"During BIO AsiaTaiwan 2025 GeneOnline visited PharmaEssentia a global biopharmaceutical company known for developing innovative therapies for hematologic malignancies cancers and immune-related diseases. The company outlined its four strategic pillars for growth: 1) Ropeginterferon alfa-2b (BESREMi) a long-acting mono-pegylated interferon already approved for polycythemia vera in the U.S. EU and Asia 2) a growing immune-oncology pipeline featuring anti-TIM-3 and anti-PD-1 checkpoint inhibitors 3) its proprietary PEGylation platform for creating long-acting biologics Stay informed throughout" @GeneOnlineNews on X 2025-07-24 11:04:43 UTC 4756 followers, XX engagements
"Sarepta Therapeutics has received @FDA clearance to resume shipments of ELEVIDYS for ambulatory patients with Duchenne muscular dystrophy (DMD) after a voluntary pause prompted by safety concerns. While shipments remain paused for non-ambulatory patients due to serious risks this decision is a positive step forward for younger patients still able to walk. ELEVIDYS is the only FDA-approved gene therapy targeting the underlying cause of DMD. Delivered via a single dose using an adeno-associated virus it offers hope to families seeking treatment options. Sareptas CEO Douglas S. Ingram emphasized" @GeneOnlineNews on X 2025-07-30 03:14:49 UTC 4755 followers, XX engagements
"As part two of Session A-11 on digital health at BIO AsiaTaiwan 2025 experts from Google Health2Sync Far EasTone Telecommunication Acer Medical and Deloitte Taiwan presented practical use cases demonstrating how digital health innovations are driving real-world clinical and operational impact. Tony Lee of Google discussed AI collaborations with Taiwans National Health Insurance Administration to predict diabetes onset and improve early intervention. Ed Deng of Health2Sync shared how the company is scaling chronic disease management across Asia through data-driven patient-centric tools. Peter" @GeneOnlineNews on X 2025-07-25 12:02:34 UTC 4757 followers, XX engagements
"Biotech Without Borders Innovating the Future At this year's BIO AsiaTaiwan 2025 conference My Linh Kha Senior Vice President and General Manager of Japan Asia Pacific at @Amgen delivered a keynote speech on "Biotech Without Borders: Unlocking the Future Through Innovation and Collaboration." She also shared her perspective on AI and innovation at Amgen with GeneOnline. "Innovation can and should move at the speed of need." My Linh Kha Three Key Takeaways: - Amgen's Foundation of Success: Rooted in a commitment to "pioneering science" an "unwavering commitment to patients" and a deep "belief" @GeneOnlineNews on X 2025-07-26 08:41:25 UTC 4754 followers, XXX engagements